Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
aggrenox
air transport
Alberta Stroke Program Early CT score
algorithm
andexanet
aneurysm, intracranial
angiography, neurologic complications with
angiotensin-converting enzyme, inhibitors
anterior cerebral artery, occlusion of
anticoagulant, complications of
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
antihypertensive
aptiganel
arterial dissection
arterial dissection, basilar
arterial dissection, carotid
arterial dissection, recurrent
arterial dissection, vertebral
arterial perforation
Asians
aspirin
aspirin, dose of
ataxia
atorvastatin
atrial fibrillation
atrial fibrillation, risk stratification
atrial myxoma
atypical
AURORA
baroreceptors
BASICS trial
basilar artery occlusion
basilar artery plaque
basilar artery stenosis
BASIS trial
BEST trial
blacks
blood pressure
blood pressure after stroke
brainstem, infarction of
brainstem, lesion of
call 911
cardioseal device
cardiovascular disease
carotid angiogram
carotid artery disease
carotid artery disease, medical management
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery stenosis
carotid artery stenosis, intracranial
carotid-siphon stenosis
CASSISS trial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, contrast extravasation
CAT scan, dense artery sign
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
cerebellar infarction
cerebral atherosclerosis
cerebral atherosclerosis, medical management
cerebral embolism
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral ischemia
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, adolescent
cerebrovascular accident, age of lesion
cerebrovascular accident, anticoagulant treatment
cerebrovascular accident, awakening with
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, classification
cerebrovascular accident, complications with
cerebrovascular accident, cost of
cerebrovascular accident, delay in treatment
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, large
cerebrovascular accident, large ischemic core
cerebrovascular accident, nonarterial territory
cerebrovascular accident, nontreatment of
cerebrovascular accident, pathophysiology
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prehospital screening
cerebrovascular accident, prehospital treatment
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, rehabilitation of
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, sex distribution
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery
cerebrovascular accident, time of onset
cerebrovascular accident, time of presentation
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, treatment of
CHADS-VaSC score
CHANCE Trial
CHOICE trial
cholesterol
citicoline
clinical mismatch
Clinical Pathologic Conference(C.P.C.)
clinical trials
clopidogrel
CLOSURE I trial
clot retrieval
collateral circulation
color desaturation
coma
complications
controversies in neurology
coronavirus
cortical infarction, small
cortical vein thrombosis
cost
cost effectiveness
coumarin
COVID-19
craniectomy, decompressive
critical pathway
dabigatran
dabigatran, dose
DAWN stroke trial
decerebrate posture
DEFUSE study
dense basilar artery sign
dense middle cerebral artery sign
diplopia
dipyridamole
disability rating scale, neurological
disability, neurological
diuretic
dizziness
doll's head maneuver
door to imaging time
door to needle time
door to reperfusion time
door to treatment time
drop attacks
dural sinus thrombosis
dysarthria
edema, facial
efficacy
embolic stroke of unknown source
embolism
embolism, paradoxical
embolism, vertebral-basilar artery
emergencies, neurologic
emergency medical technicians
endarterectomy, carotid
endarterectomy, carotid-indications for
endovascular photoacoustic recanalization
endovascular therapy
endovascular therapy, late time window
endovascular therapy, selection criteria
endovascular therapy, time window
epidemic
epidemiology of neurology
EPITHET trial
ESCAPE trial
ethics in neurology
EXTEND trial
factor Xa inhibitor
failed medical management
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fibroblast growth factor
gastrointestinal bleeding
gaze palsy
gender
GOLIATH trial
HAS-BLED score
head injury
headache
headache, thunderclap
hemorrhagic diathesis
heparin
heparin, low-molecular-weight
hepatic failure
heprain induced thrombocytopenia
HERMES
herpes simplex encephalitis, diagnosis of
hospital length of stay
hypercoagulable state
hyperintense vessel sign
hypertension
iatrogenic neurologic disorders
idarucizumab
indapamide
informed consent
INR value, time in range
INR values
internal carotid artery
intracerebral hemorrhage
intracranial hemorrhage
intracranial pressure, increased
ischemic core
ischemic penumbra
lawsuit
lipid lowering agent
lipids
liver disease
liver function enzymes
locked-in syndrome
malpractice
mastoiditis
MATCH trial
medical-legal aspects of neurology
MERCI trial
middle cerebral artery
middle cerebral artery atherosclerosis
middle cerebral artery territory infarction
middle cerebral artery, branch occlusion
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
misdiagnosis
mobile interventional stroke teams
mortality
MR CLEAN
MR WITNESS trial
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, FLAIR, hyperintense vessels
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, volumetry
multimodal neuroimaging
neoplasm, intracranial-incidence and epidemiology of
neurologic consultation
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic symptoms
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
NMDA antagonists
non-vitamin K antagonist oral anticoagulants
nystagmus
old age, neurology of
outcome research
palliative care
patent foramen ovale
patent foramen ovale, percutaneous closure
patient information and support
patient selection
Penumbra System
perindopril
platelet inhibiting drugs
platelet inhibiting drugs, combined
POINT trial
pons, infarction of
posterior cerebral artery occlusion
posterior circulation stroke
practice guidelines
prevention of neurologic disorders
PROFESS trial
prognosis
PROGRESS trial
quality of life
ramipril
Rankin score
RAPID CT perfusion maps
recanalization, arterial
recanalization, venous
recurrent
rehabilitation for neurologic disorders
RELY trial
reperfusion
research
RESPECT trial
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
risk factors, modification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
screening
seizure
seizure, focal
serum alanine aminotransferase
solitaire device
SPARCL trial
SPORTIF trial
STARFlex septal closure system
statin therapy
stent, carotid artery
stent, coronary artery
stent, intracranial
stent, middle cerebral artery
stent, vertebral artery
streptokinase
stroke center
stroke disability scale
stroke protocol
stroke unit, mobile
subarachnoid hemorrhage
subdural hematoma
superior sagittal sinus thrombosis
SWIFT PRIME Trials
SWIFT trial
symptomatic
T lesion of MCA-ICA
telemedicine
teleneurology
telestroke
tenecteplase
thrombectomy
thrombectomy, distal occlusion
thrombin inhibitor
thromboaspiration
thrombolysis, mechanical
time is brain
TIMELESS trial
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
transluminal angioplasty, basilar artery
transluminal angioplasty, carotid artery
transluminal angioplasty, intracranial
transluminal angioplasty, intracranial-indications for
transluminal angioplasty, middle cerebral artery
transluminal angioplasty, vertebral artery
transport of patient
trauma
treatment delay
treatment of neurologic disorder
Trevo retriever
trial design
unconsciousness
unconsciousness, transient
urokinase
vaccination, neurologic complications with
vaccine
vertebral artery
vertebral artery occlusion
vertebral artery stenosis
vertebral-basilar artery, atherosclerosis
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertigo
vision, blurred
VISSIT trial
visual field defect
WAKE-UP trial
WASID trial
weakness, generalized
Wingspan study
workup
ximelagatran
Showing articles 1050 to 1100 of 2192 << Previous Next >>

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease
Arch Neurol 62:753-757, Sparks,D.L.,et al, 2005

Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005

Effect of Pravastatin on Cerebral Infarcts and White Matter Lesions
Neurol 64:1807-1809, ten Dam,V.H.,et al, 2005

HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcomes
Stroke 36:1298-1300, Moonis,M.,et al, 2005

Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005

Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005

Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005

Adding Aspirin to Clopidogrel After TIA and Ischemic Stroke
Neurol 64:1117-1121, Hankey,G.J. &Eikelboom,J.W., 2005

Heparin-Induced Thrombocytopenia in Neurologic Patients Treated with Low-Molecular-Weight Heparin
Neurol 64:1285-1287, Pohl,C.,et al, 2005

Management of Acute Cerebellar Stroke
Arch Neurol 62:537-544, Jensen,M.B. &St. Louis,E.K., 2005

Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005

Expanding Indications for Statins in Cerebral Ischemia
Arch Neurol 62:67-72,23, Ovbiagele,B.,et al, 2005

Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005

Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Approval of the MERCI Clot Retriever-A Critical View
Stroke 36:400-403, Becker, K.J.., & Brott, T.G., 2005

Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005

Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005

Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005

Efficacy of Aspirin Plus Extended-Release Dipyridamole in Preventing Recurrent Stroke in High-Risk Populations
Arch Neurol 62:403-408, Sacco, R.L., et al, 2005

Sonothrombolysis in Acute Ischemic Stroke for Patients Ineligible for rt-PA
Neurol 64:1052-1054, Eggers,J., et al, 2005

Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005

Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005

Gene Transfer for Neurologic Disease
Neurol 63:2225-2232, Mendell,J.R. &Miller,A., 2004

Intra-Arterial Thrombolysis of Complete Deep Cerebral Venous Thrombosis
Neurol 63:2444-2445, Liebetrau,M.,et al, 2004

Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004

Access to Intra-Arterial Therapies for Acute Ischemic Stroke: An Analysis of the US Population
AJNR 25:1802-1806, Suzuki,S.,et al, 2004

Anticoagulants for Acute Ischemic Stroke
Stroke 35:2916-2917, Sandercock,P.,et al, 2004

Thrombolysis for Acute Ischemic Stroke
Stroke 35:2914-2915, Wardlaw,J.,et al, 2004

Statins in Stroke Prevention and Carotid Artherosclerosis, Systematic Review and Up-to-Date Meta-Analysis
Stroke 35:2902-2909, Amarenco,P.,et al, 2004

Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Anticoagulation Rather Than Stockings Alone: Against
Stroke 35:2912-2913,2910, Dennis,M.S., 2004

Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Angicoagulation Rather Than Stockings Alone: For
Stroke 35:2911-2912,2910, Adams,H.P., 2004

Incidence of Hospitalized Rhabdomyloysis in Patients Treated With Lipid-Lowering Drugs
JAMA 292:2585-2590, Graham,D.J.,et al, 2004

Statin-Associated Exacerbation of Myasthenia Gravis
Neurol 63:2188, Cartwright,M.S.,et al, 2004

Fibrinogen-Depleting Agents for Acute Ischemic Stroke
Stroke 36:173-174, Liu,M.,et al, 2004

Immediate Computed Tomography Scanning of Acute Stroke is Cost-Effective and Improves Quality of Life
Stroke 35:2477-2483, Wardlaw,J.M.,et al, 2004

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
NEJM 351:2170-2178, Alexandrov,A.V.,et al, 2004

Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR 25:1470-1475, Lee,K.Y.,et al, 2004

Predictors of In-Hospital Mortality in Patients with Acute Ischemic Stroke Treated with Thrombolytic Therapy
JAMA 292:1831-1838, Heuschmann,P.U.,et al, 2004

Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004

Long-Term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion
JAMA 292:1862-1866, Lindsberg,P.J.,et al, 2004

Thrombolytic Therapy in Stroke-Related Trauma
Conn Med 68:551-553, Finelli,P.F. &Beland,D., 2004



Showing articles 1050 to 1100 of 2192 << Previous Next >>